Chembio Diagnostics Earnings Estimate

CEMI
 Stock
  

USD 0.67  0.02  3.08%   

Many public companies, such as Chembio Diagnostics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Chembio Diagnostics' earnings estimates, investors can diagnose different trends across Chembio Diagnostics' analyst sentiment over time as well as compare current estimates against different timeframes.
Chembio Diagnostics is projected to generate -1.04 in earnings per share on the 31st of December 2021. Chembio Diagnostics earnings estimates module stress-tests analyst consensus about projected Chembio Diagnostics EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Continue to Trending Equities.
  
Refresh
The current Gross Profit is estimated to decrease to about 13.3 M. The current Profit Margin is estimated to decrease to -0.73

Chembio Diagnostics Earnings Estimation Breakdown

Calculation of earning per share of Chembio Diagnostics is based on official Zacks consensus of 1 analysts regarding Chembio Diagnostics future annual earnings. Given the historical accuracy of 86.04%, the future earnings per share of Chembio Diagnostics is estimated to be -1.04 with the lowest and highest values of -1.04 and -1.04, respectively. Please note that this consensus of annual earnings estimates for Chembio Diagnostics is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS -1.24
-1.04
Lowest
Expected EPS -1.04
-1.04
Highest

Chembio Diagnostics Earnings Projection Consensus

Suppose the current estimates of Chembio Diagnostics' value are higher than the current market price of the Chembio Diagnostics stock. In this case, investors may conclude that Chembio Diagnostics is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Chembio Diagnostics' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

1

86.04%

-1.241

-1.04

Chembio Diagnostics Earnings History

Earnings estimate consensus by Chembio Diagnostics analysts from Wall Street is used by the market to judge Chembio Diagnostics' stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Chembio Diagnostics' upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.

Chembio Diagnostics Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

(7.45 Million)

Share
The current Accumulated Retained Earnings Deficit is estimated to decrease to about (134.5 M). The current Earning Before Interest and Taxes EBIT is estimated to decrease to about (31.9 M) The current Issuance Purchase of Equity Shares is estimated to increase to about 42 M, while Weighted Average Shares is projected to decrease to roughly 20.2 M.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Chembio Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Chembio Diagnostics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.030.6710.10
Details
Intrinsic
Valuation
LowReal ValueHigh
0.030.6410.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Chembio Diagnostics. Your research has to be compared to or analyzed against Chembio Diagnostics' peers to derive any actionable benefits. When done correctly, Chembio Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Chembio Diagnostics.
Note that many institutional investors and large investment bankers can move markets due to the volume of Chembio assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Chembio Diagnostics. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Chembio stock price in the short term.

Chembio Diagnostics Earnings per Share Projection vs Actual

Actual Earning per Share of Chembio Diagnostics refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Chembio Diagnostics predict the company's earnings will be in the future. The higher the earnings per share of Chembio Diagnostics, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Chembio Diagnostics Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Chembio Diagnostics, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Chembio Diagnostics should always be considered in relation to other companies to make a more educated investment decision.

Chembio Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Chembio Diagnostics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-05-05
2022-03-31-0.21-0.29-0.0838 
2022-03-03
2021-12-31-0.2-0.47-0.27135 
2021-11-04
2021-09-30-0.19-0.24-0.0526 
2021-08-05
2021-06-30-0.3667-0.45-0.083322 
2021-05-06
2021-03-31-0.3167-0.220.096730 
2021-03-11
2020-12-31-0.2767-0.35-0.073326 
2020-11-05
2020-09-30-0.26-0.28-0.02
2020-08-06
2020-06-30-0.395-0.42-0.025
2020-05-04
2020-03-31-0.2275-0.29-0.062527 
2020-03-12
2019-12-31-0.245-0.230.015
2019-11-07
2019-09-30-0.17-0.22-0.0529 
2019-08-06
2019-06-30-0.1525-0.19-0.037524 
2019-05-01
2019-03-31-0.15-0.16-0.01
2019-03-07
2018-12-31-0.1675-0.21-0.042525 
2018-11-08
2018-09-30-0.12-0.16-0.0433 
2018-08-08
2018-06-30-0.07-0.12-0.0571 
2018-05-09
2018-03-31-0.14-0.050.0964 
2018-03-08
2017-12-31-0.1067-0.16-0.053349 
2017-11-08
2017-09-30-0.11-0.050.0654 
2017-08-09
2017-06-30-0.165-0.18-0.015
2017-05-09
2017-03-31-0.195-0.130.06533 
2017-03-07
2016-12-31-0.1667-0.21-0.043325 
2016-11-10
2016-09-30-0.1733-0.19-0.0167
2016-08-11
2016-06-30-0.17-0.86-0.69405 
2016-05-12
2016-03-31-0.09-0.030.0666 
2016-03-08
2015-12-31-0.0733-0.070.0033
2015-11-12
2015-09-30-0.07-0.050.0228 
2015-08-06
2015-06-30None-0.07None
2015-05-07
2015-03-31-0.11-0.070.0436 
2015-03-05
2014-12-31-0.03-0.05-0.0266 
2014-11-06
2014-09-30-0.02-0.03-0.0150 
2014-08-07
2014-06-30-0.02-0.020
2014-05-08
2014-03-31-0.01-0.02-0.01100 
2014-03-06
2013-12-310.04-0.03-0.07175 
2013-11-07
2013-09-300.080.07-0.0112 
2013-08-08
2013-06-30-0.04-0.030.0125 
2013-05-09
2013-03-310.020.040.02100 
2013-03-07
2012-12-310.050.060.0120 
2012-11-13
2012-09-300.04-0.04-0.08200 
2012-08-09
2012-06-300.030.040.0133 
2012-05-08
2012-03-31None0.08None
2012-03-08
2011-12-31None0.6639None
2011-11-03
2011-09-30None0.0558None
2011-08-04
2011-06-30None0.0225None
2011-05-05
2011-03-31None-0.0183None
2011-03-03
2010-12-31None0.24None
2010-11-04
2010-09-30None0.019None
2010-07-29
2010-06-30-0.080.080.16200 
2010-05-06
2010-03-31None-0.0203None
2010-03-05
2009-12-31None0.0329None
2009-11-05
2009-09-30None0.0326None
2009-08-07
2009-06-30None0.0118None
2009-05-08
2009-03-31None-0.042None
2008-11-12
2008-09-30-0.08-0.03060.049461 
2008-08-04
2008-06-30-0.08-0.080
2008-05-12
2008-03-31-0.16-0.080.0850 
2008-03-12
2007-12-31-0.8-2.56-1.76220 
2007-11-01
2007-09-30-0.96-0.560.441 
2007-08-09
2007-06-30None-0.6541None
2007-05-11
2007-03-31-1.04-0.720.3230 
2007-03-29
2006-12-31-0.96-1.84-0.8891 
2006-11-14
2006-09-30None-1.703None
2006-08-14
2006-06-30None-1.0656None
2006-05-15
2006-03-31None-1.7237None
2005-11-14
2005-09-30None-1.0207None
2005-08-14
2005-06-30None-1.1733None
2005-05-15
2005-03-31None-4.0322None
2005-03-23
2004-12-31None-3.52None
2004-11-15
2004-09-30None-1.4336None
2004-08-17
2004-06-30None-1.0478None
2004-05-13
2004-03-31None-0.72None
2003-11-15
2003-09-30None0.0068None
2003-08-17
2003-06-30None-0.0076None
2003-03-31
2003-03-31None0.0513None
2002-12-31
2002-12-31None-0.0402None
2001-06-30
2001-06-30None0.1218None

About Chembio Diagnostics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Chembio Diagnostics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Chembio Diagnostics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Chembio Diagnostics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit-131 M-134.5 M
Earning Before Interest and Taxes EBIT-31.1 M-31.9 M
Earnings per Basic Share(1.40) (1.44) 
Earnings per Diluted Share(1.40) (1.44) 
Price to Earnings Ratio(0.81) (0.83) 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA-28.1 M-28.9 M
Earnings before Tax-34 M-34.9 M
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care diagnostic tests that are used to detect or diagnose diseases. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York. Chembio Diagnostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 337 people.

Chembio Diagnostics Investors Sentiment

The influence of Chembio Diagnostics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chembio. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Chembio Diagnostics Implied Volatility

    
  0.0  
Chembio Diagnostics' implied volatility exposes the market's sentiment of Chembio Diagnostics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Chembio Diagnostics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Chembio Diagnostics stock will not fluctuate a lot when Chembio Diagnostics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chembio Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chembio Diagnostics' short interest history, or implied volatility extrapolated from Chembio Diagnostics options trading.

Current Sentiment - CEMI

Chembio Diagnostics Investor Sentiment

Most of Macroaxis users are currently bullish on Chembio Diagnostics. What is your opinion about investing in Chembio Diagnostics? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Pair Trading with Chembio Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Chembio Diagnostics Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.
The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
19.6 M
Quarterly Revenue Growth YOY
1.16
Return On Assets
-0.26
Return On Equity
-1.53
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.